Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Class III drug recalls - low risk

Class III means the product is unlikely to cause harm but violates FDA labeling or manufacturing rules. These are the recalls you rarely hear about; pharmacies usually just swap the affected lot.

1,716 recalls, newest first.

Class III · Low risk

Sirolimus Tablets

Failed impurities/degradation: out of specification result for impurity secorapamycin.

Terminated Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 55111-653-01 D-1063-2016
Class III · Low risk

CEFTRIAXONE for Injection USP

CGMP Deviations: Out of specification (OOS) intermediate in the subsequent processes to manufacture the final API.

Terminated Failed specification Aidarex Pharmaceuticals LLC NDC 53217-0117-01 D-0974-2016
Class III · Low risk

mitoXANTRONE Injection USP

Failed Impurities/Degradation Specifications: High out of specification results for Impurity D.

Terminated Impurity / degradation Teva North America NDC 0703-4685-01 D-1451-2016
Class III · Low risk

Irbesartan and Hydrochlorothiazide Tablets

Labeling: Incorrect or Missing Lot and/or Exp Date: Incorrect lot number, 327B160012, appears on the case label, the correct lot number, 327B16002 appears on the immediate container.

Terminated Labeling / mix-up Prinston Pharmaceutical Inc NDC 43547-331-09 D-1049-2016
Class III · Low risk

Pramipexole Dihydrochloride Extended Release Tablets

Failed Impurities/Degradation Specifications: Par Pharmaceutical is recalling Pramipexole Dihydrochloride Extended Release tablets because it contains a known product impurity above currently approved specification levels.

Terminated Impurity / degradation Par Pharmaceutical NDC 10370-251-11 D-1038-2016
Class III · Low risk

Remeven Cream

Crystallization; Complaints that cream appears to have crystallized

Completed Failed specification Stratus Pharmaceuticals Inc D-1464-2016
Class III · Low risk

Oxycodone HCl

Failed Impurities/Degradation Specification; 9 month stability

Terminated Impurity / degradation West-Ward Columbus Inc NDC 0054-0390-41 D-1441-2016
Class III · Low risk

Doxycycline

Labeling: Incorrect Or Missing Lot and/or Exp Date: Some expiries and lot numbers are missing.

Terminated Labeling / mix-up Galderma Laboratories, L.P. D-1031-2016
Class III · Low risk

Mycophenolate Mofetil

cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration

Terminated cGMP deviation Attix Pharmaceuticals Inc D-1047-2016

Recalls by year